Canaccord Genuity reiterates a 'Buy' on EnteroMedics (NASDAQ: ETRM) price target of $5.00.

Analyst, William J. Plovanic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE